COX-2 inhibitors in oncology

Characteristics of Patients and Prognostic Factors Across Treatment Lines in Metastatic Colorectal Cancer: An Analysis From the Aide et Recherche en Cancérologie Digestive Database.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2025

Prognostic Impact of Early Treatment and Oxaliplatin Discontinuation in Patients With Stage III Colon Cancer: An ACCENT/IDEA Pooled Analysis of 11 Adjuvant Trials.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2022

Pharmacogenetic study in gastric cancer patients treated with adjuvant fluorouracil/leucovorin or epirubicin/cisplatin/fluorouracil before and after chemoradiation on CALGB 80101 (Alliance).

Pharmacogenetics and genomics·2021

Benefit of Oxaliplatin in Stage III Colon Cancer According to IDEA Risk Groups: Findings from the ACCENT Database of 4934 Patients.

Clinical colorectal cancer·2021

Sex and Adverse Events of Adjuvant Chemotherapy in Colon Cancer: An Analysis of 34 640 Patients in the ACCENT Database.

Journal of the National Cancer Institute·2020

Update on optimal treatment for metastatic colorectal cancer from the AGITG expert meeting: ESMO congress 2019.

Expert review of anticancer therapy·2020

A bibliometric analysis of research evolution on peritoneal metastasis in colorectal cancer (2000-2026): advances in molecular mechanisms and therapeutic strategies.

Seminars in oncology·2026

Circumferential lymphadenectomy around the SMA in pancreatic head cancer: A single-center experience.

Seminars in oncology·2026

From imaging to action: MRI features direct surgical strategy in low rectal cancer.

Seminars in oncology·2026

Genetic and systems-level regulation of cancer metabolism: From metabolic reprogramming to AI-driven precision oncology.

Seminars in oncology·2026

Regulation of PD-1 and PD-L1 expression in tumor immune microenvironment.

Seminars in oncology·2026

Clostridioides difficile infection in hematologic malignancy patients with and without bone marrow transplantation: A nation-wide cross-sectional study.

Seminars in oncology·2026

[Effect of ESR1 Somatic Mutations on SERM/SERD Binding: Insights from Molecular Docking and Molecular Dynamics Simulations].

Molekuliarnaia biologiia·2026

RASA2 Promotes Pancreatic Cancer Metastasis by Activating TGFβ-Dependent Non-canonical Hedgehog Signaling.

Cancer research·2026

BRIGHTLINE-1: When a Negative Trial Reveals Two Active Therapies.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026

The pan-tumor landscape, allelic status, and genomic complexity of SMARCA4 alterations.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026

CAR T Cells Targeting an Intracellular Leukemia Antigen Promiscuously Presented by Diverse HLA-II Alleles.

Blood cancer discovery·2026

Impact of GAD-65 Antibody Detection on Antihyperglycemic Therapy in T2D.

Endocrine connections·2026

Related Experiment Videos

COX-2 inhibitors in oncology

Related Concept Videos

Characteristics of Patients and Prognostic Factors Across Treatment Lines in Metastatic Colorectal Cancer: An Analysis From the Aide et Recherche en Cancérologie Digestive Database.

Prognostic Impact of Early Treatment and Oxaliplatin Discontinuation in Patients With Stage III Colon Cancer: An ACCENT/IDEA Pooled Analysis of 11 Adjuvant Trials.

Pharmacogenetic study in gastric cancer patients treated with adjuvant fluorouracil/leucovorin or epirubicin/cisplatin/fluorouracil before and after chemoradiation on CALGB 80101 (Alliance).

Benefit of Oxaliplatin in Stage III Colon Cancer According to IDEA Risk Groups: Findings from the ACCENT Database of 4934 Patients.

Sex and Adverse Events of Adjuvant Chemotherapy in Colon Cancer: An Analysis of 34 640 Patients in the ACCENT Database.

Update on optimal treatment for metastatic colorectal cancer from the AGITG expert meeting: ESMO congress 2019.

A bibliometric analysis of research evolution on peritoneal metastasis in colorectal cancer (2000-2026): advances in molecular mechanisms and therapeutic strategies.

Circumferential lymphadenectomy around the SMA in pancreatic head cancer: A single-center experience.

From imaging to action: MRI features direct surgical strategy in low rectal cancer.

Genetic and systems-level regulation of cancer metabolism: From metabolic reprogramming to AI-driven precision oncology.

Regulation of PD-1 and PD-L1 expression in tumor immune microenvironment.

Clostridioides difficile infection in hematologic malignancy patients with and without bone marrow transplantation: A nation-wide cross-sectional study.

[Effect of ESR1 Somatic Mutations on SERM/SERD Binding: Insights from Molecular Docking and Molecular Dynamics Simulations].

RASA2 Promotes Pancreatic Cancer Metastasis by Activating TGFβ-Dependent Non-canonical Hedgehog Signaling.

BRIGHTLINE-1: When a Negative Trial Reveals Two Active Therapies.

The pan-tumor landscape, allelic status, and genomic complexity of SMARCA4 alterations.

CAR T Cells Targeting an Intracellular Leukemia Antigen Promiscuously Presented by Diverse HLA-II Alleles.

Impact of GAD-65 Antibody Detection on Antihyperglycemic Therapy in T2D.

Related Experiment Videos

COX-2 inhibitors in oncology

Related Concept Videos

Related Articles